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1. Introduction 
Some of the smallest self-replicating bacteria, the wall-less mycoplasmas belonging to Class 
Mollicutes, are pathogenic for mammals and humans, showing tissue and host-specificity. 
In humans, the pathogenic species of the Mycoplasma or Ureaplasma genus cause covert 
infections that tend to chronic diseases. At present, 7 species of Mycoplasma, 2 species of 
Ureaplasma and 1 of Acholeplasma have been consistently isolated/detected from several 
specimens from diseased subjects, specially through the use of molecular detection 
techniques [Mendoza et al., 2011; Waites & Talkington, 2005; Waites, 2006].  
Current laboratory diagnosis of these infections relies on cultural methods, however this is 
complicated and emission of results may delay up to 5 weeks. Thus development and 
application of molecular methods, such as polymerase chain reaction (PCR), have allowed 
direct detection in clinical specimens and shortened the time to get the final results. 
Nevertheless some pitfalls still hampers the widespread use of these technologies, mainly 
due to technical difficulties in collecting representative specimens and optimizing sample 
preparation. There are countless reports on new nucleic acid-based tests (NATs) for 
mycoplasma detection, however there is a great variation between methods from study to 
study, including variability of target gene sequences, assay format and technologic platform 
[Waites et al., 2000; Waites , 2006;]. 
The processing of the clinical samples is crucial for the improvement of PCR assays as part 
of routine diagnostic approaches. In general, for the strength of performance of any 
diagnostic PCR, the overall setting-up of the assay should consider the following four basic 
steps:  1) sampling, 2) sample preparation, 3) nucleic acid amplification, and 4) detection of 
PCR products [Rådström et al., 2004].  
As occurred with much of the emerging or reemerging pathogens, the molecular detection 
plays a key role in the discovery, identification and association or such pathogens with 
human disease [Relman & Persing, 1996]. Nevertheless, routine clinical microbiology 
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laboratories still lack of skilled personnel in molecular detection techniques, and 
consequently in the appropriate sample preparation procedures [Cassell et al, 1994a; 
Talkington & Waites, 2009]. Unlike other fast-growing pathogens, the pathogenic Mollicutes 
species exhibit unique features that make them the last link in the diagnostic chain, only 
sought after failure in other diagnostic approaches [Cassell et al., 1994a]. 
2. Relevant features of mycoplasmas 
The term mycoplasmas will be used to refer to any member of the Class Mollicutes. The 
mycoplasmas are the smallest microorganisms (0.3 - 0.8 µm diameter) capable of self-
replication, which lack a rigid cell wall. These bacteria also incorporate exogenous 
cholesterol into their own plasma membrane and use the UGA codon to encode tryptophan. 
Due to their reduced cell dimensions, they possess small genome sizes (0.58-2.20 Mb) and 
exhibit restricted metabolic alternatives for replication and survival. As a result of the above 
mentioned, the mycoplasmas show a strict dependence to their hosts for acquisition of 
biosynthetic precursors (aminoacids, nucleotides, lipids and sterols), in a host- and tissue-
restricted manner, reflecting their nutritional demands and parasitic lifestyle [Baseman & 
Tully, 1997; Razin, 1992; Razin et al., 1998].  
Mycoplasmas infecting humans mainly colonize the mucosal surfaces of the respiratory and 
genitourinary tracts [Cassell et al., 1994, Patel & Nyirjesy, 2010; Taylor-Robinson, 1996]. The 
mycoplasma species commonly isolated from humans and their attributes are listed in Table 
1. Of the pathogenic species, Mycoplasma pneumoniae is found principally in the respiratory 
tract, whereas M. genitalium, Ureaplasma parvum, U. urealyticum., M. hominis, M. fermentans  
 
Species 
Primary colonization sites Main metabolic substrates 
Pathogenicity Respiratory 
tract 
Urogenital 
tract 
Glucose Arginine Urea 
Mycoplasma. salivarium 
M. orale 
M. buccale 
M. faucium 
M. lipophilum 
M. pneumoniae 
M. hominis 
M. genitalium 
M. fermentans 
M. primatum 
M. spermatophilum 
M. pirum 
M. penetrans 
Ureaplasma urealyticum
U. parvum 
Acholeplasma laidlawii 
A. oculi 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
- 
- 
¿? 
- 
+ 
+ 
+ 
¿? 
- 
- 
- 
- 
- 
- 
+ 
+ 
+ 
+ 
+ 
¿? 
+ 
+ 
+ 
- 
- 
- 
- 
- 
- 
- 
+ 
- 
+ 
+ 
- 
- 
+ 
+ 
- 
- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
- 
+ 
- 
+ 
+ 
+ 
+ 
+ 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
+ 
+ 
- 
- 
- 
- 
- 
- 
- 
+ 
+ 
+ 
+a 
- 
- 
- 
+b,c 
+ 
+ 
- 
- 
aLo et al,1993; bLo et al, 1992; cYáñez et al., 1999.  
Table 1. Mycoplasmas which infect humans.  
Adapted from: Taylor-Robinson, 1996. 
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and M. penetrans are primarily urogenital residents, but exceptionally they can be isolated 
from other unusual tissues and organs, especially in immunocompromised patients or in 
patients undergoing solid organ transplantation [Cassel et al., 1993; Waites & Talkington, 
2004; Waites et al, 2005; Waites et al., 2008]. 
Most of mycoplasmal diseases are underdiagnosed because the specific laboratory diagnostic 
strategies are quite different than those for fast-growing bacteria. It is noteworthy that 
mycoplasmal etiology of diseases in humans is considered only after failure of diagnosis of 
other common bacterial etiologies. In addition, outside their hosts, the mycoplasmas are highly 
labile to environmental factors, such as changing osmotic pressure and temperature, 
desiccation and/or alkaline or acidic conditions [Cassell et al., 1994a; Waites et al., 2000]. 
Noteworthy, there are few specialized or reference laboratories for diagnosis of mycoplasmal 
diseases and therefore, limited skilled laboratory personnel [Cassell et al., 1994a].   
3. Routine laboratory diagnostic approaches  
Several different detection techniques of mycoplasmal infections have been developed, each 
one of which has its advantages and limitations with respect to cost, time, reliability, 
specificity, and sensitivity. According to the laboratory’s infrastructure, the most common 
methods include: a) culture-based isolation/detection/identification/antimicrobial 
susceptibility profile; b) antigen detection, c) mycoplasmal-specific serologic responses; and, 
d) PCR and other NATs. [Razin et al., 1998; Talkington & Waites, 2009; Waites et al., 2000; 
Yoshida et al., 2002]. 
3.1 Culture 
Relationship between mycoplasmas as etiologic agents and diseases in humans remains 
doubtful due to unsuccessful isolation/detection of these microorganisms in specimens 
from affected persons, as compared with healthy carriers [Taylor-Robinson, 1996].  
Demonstration of growth of mycoplasma, by means of in vitro culture from clinical 
specimens, is still required to link the pathogen with the disease; thus culture is considered 
as the Gold Standard. However, current culture methods for detection of mycoplasmas in 
clinical specimens are arduous and emission of results may delay up to 5 weeks, which even 
then may be inconclusive or inaccurate [Cassell et al., 1994a; Waites et al., 2000].  
In this context, detection or isolation of mycoplasmas from clinical specimens requires 
careful consideration of the type of specimen available and the organism (species) sought 
[Cassell et al., 1994a]. The adequate specimens for culture include: a) normally sterile body 
fluids (sinovial, amniotic, cerebrospinal, urine, peritoneal, pleural, etc., b) secretions 
exudates or swabs from sites with associated flora (from nasopharinx, pharinx, cervix, 
vagina, urethra, surgical wounds, prostate, sputum, etc.), and c) cell-rich fluids (including 
blood and semen) or tissue biopsies. Overall, specimen collection should reflect the site of 
infection and/or the disease process. [Atkinson et al., 2008; Waites & Talkington, 2004].  
Liquid specimens or tissues do not require special transport media if culture can be 
performed within 1 hour, otherwise specimens should be placed in transport media, such as 
SP-4, 10B or 2SP broths. When swabbing is required, aluminum- or plastic-shafted calcium 
alginate or dacron swabs should be used, taking care to obtain as many cells as possible 
[Atkinson et al., 2008; Cassell et al., 1994a; Waites, 2006]. 
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There is no ideal formulation of culture media for all pathogenic species, mainly due to their 
different substrate and pH requirements [Waites et al., 2000]. Modified SP-4 media (broth 
and agar) [Lo et al., 1993a], containing both glucose and arginine, can support the growth of 
all human pathogenic Mycoplasma species, including the fastidious M. pneumoniae and M. 
genitalium. A set of Shepard´s 10B broth and A8 agar can be used for cultivation of 
Ureaplasma species and M. hominis. For cultivation, specimens in transport media should be 
thoroughly mixed, and then should be 10-fold serially diluted in broth (usually up to 10-6) in 
order to allow semiquantitative estimation of mycoplasmal load, but subcultures in agar 
media should also be performed [Cassel et al., 1994a]. Inoculated media should be incubated 
under microaerophilic atmosphere at 37 °C. 
Detection of M. pneumoniae in broth culture is based on its ability to ferment glucose, 
causing an acidic shift after 4 or more weeks, readily visualized by the presence of the 
phenol red pH indicator. Broths with any color change, and subsequent blind broth 
passages, should be subcultured to SP4 agar, incubated, and examined under the low-power 
objective of the light microscope in order to look for development of typical “fried egg”-like 
colonies of up to 100 μm in diameter. Examination of agar plates must be done on a daily 
basis during the first week, and thereafter every 3 to 4 days until completing 5 weeks or 
until growth is observed [Waites et al., 2000; Waites & Talkington, 2004]. M. genitalium, M. 
fermentans and M. penetrans are also glucose-fermenting and form colonies morphologically 
indistinguishable from those of M. pneumoniae, thus serologic-based definitive identification 
can be done by growth inhibition, metabolic inhibition, and mycoplamacidal tests [Atkinson 
et al., 2008]. 
Hidrolysis of urea by Ureaplasma and hidrolysis of arginine by M. hominis cause an alkaline 
shift, turning the colour of 10B broth from yellow to pink. Tiny brown or black irregular 
colonies of Ureaplasma species develop between 1-5 days on A8 agar plates, due to urease 
activity in the presence of manganese sulfate. Typical fried egg colonies are produced by M. 
hominis in this medium [Cassell et al, 1994a; Waites et al., 2000].  
3.2 Molecular assays 
The nucleic acid-based techniques have several advantages over culture-based methods, 
including rapid results, low detection limits (theoretically a single copy of target sequence), 
and specific organism detection.  This is critical in a hospital setting, since rapid pathogen 
detection is important for faster and improved patient treatment and consequently for 
shortening hospitalization time [Mothershed & Whitney, 2006].  
In particular, for PCR-based detection tests, selection of the appropriate target sequences for 
amplification appears to be of major concern. Mycoplasmal sequences to be amplified can be 
chosen from published gene sequences or from a mycoplasma-specific cloned DNA 
fragments [Kovacic et al., 1996; Razin, 2002]. The accelerated rate of genomic sequencing has 
led to an abundance of completely sequenced genomes. Annotation of the open reading 
frames (ORFs) (i.e., gene prediction) in these genomes is an important task and is most often 
performed computationally based on features in the nucleic acid sequence [Jaffe et al., 2004; 
Razin 2002]. Besides complete or almost complete sequences of the 16S rRNA genes for 
almost all the established mycoplasma species, the published full genome sequences of the 
human pathogenic mycoplasma species [Fraser et al., 1995; Glass et al., 2000; Himmelreich et 
al., 1996] will accelerate the process of identification of novel target sequences for PCR 
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diagnostics. Selection of a variety of target sequences, starting with highly conserved 
regions of the genes, allowed design of primers of wide specificity ("universal primers") 
(Table 2) for detection of mycoplasmal infections in anatomic sites where at least 2 or 3 
species are frequently found.  The use of a single Mollicutes universal primer set  in cases of 
life-threatening infections has the advantage of allowing a rapid positive or negative report 
to clinicians, and in turn to establish as soon as possible the appropriate treatment [Razin, 
1994]. The approach of using Mollicutes-specific and Ureaplasma spp-specific universal 
primers allowed better discrimination between organisms of the Mycoplasma and Ureaplasma 
genus, and subsequent identification by species-specific primers in urine specimens from 
HIV-infected patients [Díaz-García et al., 2004]. 
 
Targets Applications References 
16S rRNA gene sequence   
Conserved regions of mycoplasmal 
16S rRNA genes. 
Screening for any 
mycoplasma species in 
clinical specimens and 
cell cultures. 
van Kuppeveld et al., 
1992; 
van Kuppeveld et al., 
1994; 
Yoshida et al., 2001. 
Variable regions of mycoplasmal 
16S rRNA genes: 
Species-specific 
detection. 
Blanchard et al., 1993a; 
Grau et al., 1994; 
van Kuppeveld et al., 
1992. 
The 16S-23S intergenic regions 
Detection of cell culture 
contamination. 
Harasawa et al., 1993. 
Mycoplasmal protein genes   
P1 adhesin gene: M. pneumoniae 
Selective detection and 
typing 
Bernet et al., 1989 
MgPa adhesin gene: M. genitalium Selective detection 
Palmer et al., 1991; 
Jensen et al., 1991. 
Elongation factor tuf gene of M. 
pneumoniae 
Selective detection Lüneberg et al., 1993 
Ureasa genes: Ureaplasma spp. Genus-specific detection Blanchard et al., 1993b 
tet M gene (tetracycline-resistance 
determinant) 
Identification of 
tetracycline-resistant 
strains 
Blanchard et al., 1992 
Mba gene 
Species-specific 
detection and typing. 
Kong et al., 1996 
Repetitive genomic sequences   
Is-like elements: M. fermentans Selective detection Wang et al., 1992 
Rep elements of P1: M. pneumoniae Selective detection Ursi et al., 1992 
Table 2. Nucleic acid sequences suitable for PCR-based  mycoplasma testing 
Adapted from: Razin, 1994. 
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When differentiation of the mycoplasmas is required, a multiplex PCR system consisting of 
a universal set of primers along with primer sets specific for the mycoplasma species 
commonly involved in a given disease process can be successfully applied [Razin, 2002, 
Choppa et al., 1998]. Moreover, both conserved and variable regions within the 
mycoplasmal 16S rRNA genes can also be selected for detection at cluster-, genus- species-, 
subspecies-, biovar- or serovar-specific levels [Kong et al., 2000; Razin, 2002].   
For diagnostic purposes in mycoplasmology, the nucleic acid tests are more sensitive than 
culture, and showing a fair to good correlation with serology. PCR testing for species-
specific mycoplasmal infection are suitable for both urogenital and respiratory samples 
[Povlsen et al., 2001, 2002]. Interestingly, sample processing prior amplification must be 
optimized depending of the type of specimen to overcome the presence of undefined 
inhibitory substances for DNA polymerases, avoiding false negative results. For example, 
nasopharyngeal samples have a higher rate of PCR inhibition than throat swabs. In general, 
results obtained by means of NATs will be as good as the quality of the nucleic acid used for 
the test [Mothersehed & Whitney, 2006; Maeda et al., 2004].  
Early in the past decade, Loens et al., 2003b,  stated that the development and application of 
new nucleic acid tests (NATs) in diagnostic mycoplasmology required proper  validation 
and standardization, and performance of different NATs must be compared  with each 
other in order to define the most sensitive and specific tests. The NATs have 
demonstrated their potential to produce rapid, sensitive and specific results, and are now 
considered the methods of choice for direct detection of M. pneumoniae, M. genitalium, and  
M. fermentans [Cassell et al., 1994a; Loens et al., 2003b]. There is a great variation in 
methods used from study to  study, including variability of target gene sequences (P1, 16S 
RNA, ATPase, tuf), assay  format (single, multiplex) or technologies (end-point PCR, Real-
time PCR, NASBA) [Loens et al., 2003a, 2003b; 2010]. Also, target DNA has been obtained 
from different specimens, such as sputum, nasopharyngeal or pharyngeal swabs, 
brochoalveolar lavages or pleural fluid, and then comparisons of performance between 
these assays are difficult. For comprehensive understanding of the use of NATs for the 
detection of M. pneumoniae, genital mycoplasmas and other respiratory pathogens in 
clinical specimens, see the reviews done by Ieven, 2007; ; Lo & Kam, 2006; Loens et al., 
2003b, 2010.  
As with any other diagnostic test, PCR assays designed for mycoplasma detection in the 
clinical setting offer several advantages over other non-molecular tests, but still have 
several drawbacks to take into account (Table 3). Notwithstanding, there are several 
primer sets that have been successfully applied for diagnosis of mycoplasmal diseases in 
humans (Table 4). 
4. Importance of the specimen collection and processing 
Clinical specimens must be collected with use of strict aseptic techniques from anatomic 
sites likely to yield pathogenic microorganisms [Taylor, 1998; Wilson, 1996]. In the case of 
mycoplasmal infections, these are clinically silent or covert, thus it is important to 
differentiate between asymptomatic carriage and disease. In this context, sampling of 
representative diseased body sites is critical for successful diagnosis. 
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The usefulness of a PCR assay for diagnostic purposes is rather limited; this is partially 
explained by the presence of inhibitory substances in complex biological samples, which 
then provoke a significant reduction or even blockage of the amplification activity of DNA 
polymerases in comparison with that obtained with the use of pure solutions of nucleic 
acids. This in consequence affects the performance and the analytical sensitivity of the PCR 
assays [Lo & Kam, 2006; Vaneechoute & Van Eldere, 1997].  
 
Advantages Disadvantages
• Overcomes the need for mycoplasma 
cultivation 
• Presence of undefined inhibitors of 
DNA polymerases may yield false-
negative results.  
• Emission of results is faster than 
culture (less than 24 h vs. up to 5 
weeks) 
• Upon detection, PCR poorly 
discriminates between disease or 
carriage 
• Allows detection of antibiotic-
inhibited or uncultivable species in 
clinical specimens 
• Risk of false-positive results due to 
carryover contamination with 
amplicons from previous reactions.  
• Selective detection. Presence of nucleic 
acids from the host or from  other 
microorganisms usually do not affect 
PCR results  
• Setting-up quantitative determination 
of bacteria in clinical specimens may 
be a very complicated task. 
• Higher sensitivity than other non-
molecular diagnostic assays (culture, 
serology). 
• Performance of PCR assays for routine 
diagnostic purposes in microbiology 
laboratories is still complex and 
expensive.  
• Use as an epidemiological tool since it 
allows detection of asymptomatic 
carriers. 
• Skilled personnel are required to carry 
out tests and analysis of results. 
• Allows detection of mycoplasmas at 
the level of Family, Genus, Species, 
Subspecies and/or Type. 
• Depending on the target sequences 
used, cross reactivity with closely 
related bacteria may occur.   
Table 3. Considerations for using PCR assays in diagnosis of mycoplasma infections. 
Adapted from: Razin 1994.  
Due to the above mentioned, improvement of PCR assays for routine diagnostic purposes 
clearly should begin with optimal processing of clinical specimens prior to amplification 
reaction, thus successful amplification of the target DNA sequence can be obtained in the 
context of trace amounts of sample-associated inhibitory substances [Horz et al, 2010; Lo & 
Kam, 2006; Rådström et al., 2004; Vaneechoute & Van Eldere, 1997].  
www.intechopen.com
  
Group or species Primer sets. Sequence    (5’→3’) Target Amplicon 
Mollicutes-specífic  
Sen: 
Antisen: 
GPO-1 
MGSO 
ACT CCT ACG GGA GGC AGC AGT A  
TGC ACC ATC TGT CAC TCT GTT AAC CTC 
16S rDNA 
Sen: 
Antisen: 
My-Ins 
MGSO 
GTAATACATAGGTCGCAAGCGTTATC 
TGC ACC ATC TGT CAC TCT GTT AAC CTC 
16S rDNA 
M. fermentans 
Sen:  
Antisen:  
IP:  
RW005 
RW004 
RW006 
GGT TAT TCG ATT TCT AAA TCG CCT 
GGA CTA TTG TCT AAA CAA TTT CCC 
GCT GTG GCC ATT CTC TTC TAC GTT 
Insertion 
sequence-like 
element 
Sen:  
Antisen:  
IP:  
Mf-1 
Mf-2 
GPO-1 
GAA GCC TTT CTT CGC TGG AG 
ACA AAA TCA TTT CCT ATT CTG TC 
ACT CCT ACG GGA GGC AGC AGT A 
rDNA 16s 
M. genitalium 
Sen:  
Antisen:  
IP:  
MGS-1 
MGS-2 
MGS-I 
GAG CCT TTC TAA CCG CTG C 
GTG GGG TTG AAG GAT GAT TG 
AAG CAA CGT AGT AGC GTG AGC 
MgPa 
Adhesin 
gene 
Sen:  
Antisen:  
IP:  
MGS-1 
MGS-4 
MGS-I 
GAG CCT TTC TAA CCG CTG C 
GTT GTT ATC ATA CCT TCT GAT 
AAG CAA CGT AGT AGC GTG AGC 
MgPa 
Adhesin 
gene 
M. hominis 
Sen:  
Antisen:  
IP:  
MYCHOMP 
MYCHOMN 
MYCHOMS 
ATA CAT GCA TGT CGA GCG AG 
CAT CTT TTA GTG GCG CCT TAC 
CGC ATG GAA CCG CAT GGT TCC GTT G 
16s rDNA 
Sen:  
Antisen:  
IP:  
Mh-1 
Mh-2 
GPO-1 
TGA AAG GCG CTG TAA GGC GC 
GTC TGC AAT CAT TTC CTA TTG CAA A 
ACT CCT ACG GGA GGC AGC AGT A 
16s rDNA 
Sen:  
Antisen:  
RNAH1 
RNAH2 
CAATGGCTAATGGCCGGATACGC 
GGTACCGTCAGTCTGCAAT 
16S rDNA 
M. penetrans 
Sen:  
Antisen:  
IP:  
MYCPENETP 
MYCPENETN 
MYCPENETS 
CAT GCA AGT CGG ACG AAG CA 
AGC ATT TCC TCT TCT TAC AA 
CAT GAG AAA ATG TTT AAA GTC TGT TTG 
16s rDNA 
w
w
w
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Group or species Primer sets. Sequence    (5’→3’) Target Amplicon 
M. pneumoniae 
Sen:  
Antisen:  
IP:  
MP5-1 
MP5-2 
MP5-4 
GAA GCT TAT GGT ACA GGT TGG 
ATT ACC ATC CTT GTT GTA AGG 
CGT AAG CTA TCA GCT ACA TGG AGG 
Unknown
gene 
Sen:  
Antisen:  
IP:  
P1-F 
P1-R 
PI-P 
GCC ACC CTC GGG GGC AGT CAG- 
GAG TCG GGA TTC CCC GCG GAG G 
CTG AAC GGG GGC GGG GTG AAG G- 
P1 adhesin 
gene 
Sen:  
Antisen:  
IP:  
16S-F 
16S-R 
16S-P 
AAG GAC CTG CAA GGG TTC GT 
CTC TAG CCA TTA CCT GCT AA 
ACT CCT ACG GGA GGC AGC AGT A 
16S rDNA
 
Sen:  
Antisen:  
IP:  
MP-P11 
MP-P12 
MP-I 
TGC CAT CAA CCC GCG CTT AAC 
CCT TTG CAA CTG CTC  ATA GTA 
CAA ACC GGG CAG ATC ACC TTT 
P1 Adhesin 
gene 
Ureaplasma spp. 
Sen:  
Antisen:  
IP:  
U5 
U4 
U9 
CAA TCT GCT CGT GAA GTA TTA C 
ACG ACG TCC ATA AGC AAC T 
GAG ATA ATG ATT ATA TGT CAG GAT CA 
Urease locu
Sen:  
Antisen:  
IP:  
Uu-1 
Uu-2 
UUSO 
TAA ATG TCG GCT CGA ACG AG 
GCA GTA TCG CTA GAA AAG CAA C 
CAT CTA TTG CGA CGC TA 
16s rDNA
U. parvum 
U. urealyticum 
Sen:  
Antisen:  
UMS-125 
UMA-226- 
GTA TTT GCA ATC TTT ATA TGT TTT CG 
CAG CTG ATG TAA GTG CAG CAT TAA 
ATT C 
mba gene 
w
w
w
.intechopen.com
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Under certain conditions PCR detection/identification/confirmation of mycoplasmas could 
be attempted from culture broths used for primary isolation, whether or not it have bacterial 
growth. According to broth turbidity boiling of small aliquots can be sufficient to release the 
DNA, but presence of precipitated material may inhibit the amplification assay.  
In our experience, an alkaline shift around pH 8 frequently results in bacterial lysis, mainly 
of ureaplasmas, therefore concentration of insoluble material by ultracentifugation prior to 
DNA extraction is unproductive. This is due to spontaneous release of mycoplasmal DNA 
that easily dissolves in the aqueous phase and cannot be sedimentated by centrifugation. In 
such cases, one can take advantage of the alkaline condition to precipitate the dissolved 
DNA by adding one tenth of 1M NaCl and twice the volume of cold 100% ethanol, and 
proceed with conventional DNA extraction protocols (unpublished data). 
4.1 Exudates and secretions 
These types of specimens are fluids closely associated with mucosal surfaces, in low 
quantities, so collection should be done with the aid of swabs, cytological brush or small 
syringes. Secretions and exudates can be taken from upper respiratory airways and from 
lower genital tract, and exceptionally from surgical wounds [Waites, 2006]. 
4.1.1 Respiratory tract 
Respiratory M. pneumoniae infection can be assessed by culture and PCR in nasopharyngeal 
and oropharyngeal secretions, sputa, bronchoalveolar lavage and lung tissue obtained by 
biopsy. There are reports that nasopharyngeal and oropharyngeal specimens are equally 
effective for detection of M. pneumoniae by PCR, although it is desirable that both sites are 
screened in parallel for better diagnostic yield [Waites et al., 2008].   
When neonatal mycoplasmal infections are suspected, endotracheal, nasopharyngeal and 
throat secretions are appropriate to evaluate respiratory infection., though specimens for 
culture should be transported quickly to laboratory since they are likely to contain at least a 
few contaminating microorganisms [Waites et al., 2005].  
Presence of mucous material in this kind of specimens frequently hampers appropriate 
processing for culture or PCR. Use of aggressive mucolytic agents (NaOH, n-acetyl-cisteine) 
can damage as well the mycoplasma cells, thus thorough homogenization by wide-bore 
pippeting is required prior to culture attempt. For nucleic acid extraction, addition of starch 
has been of help to enhance recovery of total genomic DNA from sputum samples 
[Harasawa et al., 1993]. In other study, dithiotreitol was used as the mucolytic agent without 
any apparent detrimental effect on mycoplasmal DNA integrity [Raty et al., 2005].   
It this worthy to note that differential sample preparation from the same specimen may be 
necessary when testing separate single-species PCRs on BAL, as described by [de 
Barbeyrac et al., 1993]. In that report, freeze-thawing cycles were applied for sample 
preparation for M. genitalium detection, while standard DNA extraction was needed for M. 
pneumoniae detection. During a study of Finnish patients with radiologically confirmed 
pneumonia, [Raty et al., 2005], evidence further supported the notion that selection of the 
appropriate specimen is crucial for diagnosis of M. pneumoniae infection. By means of a M. 
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pneumoniae-specific 16S rDNA PCR, they obtained positive amplification frequencies of 
69%, 50% and 37.5% for sputum, nasopharyngeal aspirate and throat swab specimens, 
respectively. 
4.1.2 Urogenital tract 
Since genital tract mycoplasmas are closely associated to live epithelial cells, collection of 
exudates must be avoided and vigorous scraping of epithelia must be done to obtain as 
many cells as possible.  In this case, a higher associated flora is frequently present in the 
samples; therefore use of transport liquid media (for culture) of buffered solutions (for DNA 
extraction) is required immediately after sampling.   
4.2 Sterile body fluids  
Collection of normally sterile body fluids is made through invasive procedures, usually 
performed by physicians under aseptic conditions [Wilson, 1996]. When specimens are 
going to be collected through puncture, careful disinfection of the skin spot must be done, 
this is crucial to both avoid contamination of the specimen with the skin’s associated flora 
and to minimize the risk of introduction of bacteria into patient’s body. Clinically, access of 
mycoplasmas to sterile body sites may be associated with an underlying immune 
compromise, and probably the bacteria spread from pulmonary or genital infectious foci 
[Cassell et al., 1994b; Waites & Talkington, 2004]. Ureaplasmas and mycoplasmas should 
always be sought from synovial fluid when hypogammaglobulinemic patients develop 
acute arthritis [Waites et al., 2000].    
Since mycoplasma-containing body fluids rarely became turbid; these specimens should be 
concentrated 10-fold by high-speed centrifugation (aprox. 12,000 x g) and immediately 
resuspended in one tenth of the original supernatant if culture will be performed. Prior to 
DNA extraction, the resulting pellet can be washed 1-2 times with Hank’s balanced salt 
solution or PBS, pH 7.4.  
4.3 Cell-rich fluids and tissues 
Unlike normally sterile body fluids, blood and semen are cell-rich fluid specimens, thus 
processing for culture or PCR is quite different. It is important to note that mycoplasmas 
have the ability to invade several cell types, including leukocytes and spermatozoa 
[Andreev et al., 1995; Baseman et al., 1995; Díaz-García et al., 2006; Girón et al., 1996; Jensen et 
al., 1994; Lo et al., 1993b, Rottem, 2003; Taylor-Robinson et al., 1991; Yavlovich et al., 2004], 
consequently a high input of cells into culture media may result in a higher probability of 
detection. 
In contrast, when DNA extraction must be performed for PCR assays, depuration of the 
sample must be done, (i.e. erythrocyte lysis and selective enrichment for leukocytes in 
blood; density gradient-based purification of spermatozoa). Noteworthy, the average 
content of leukocyte DNA per milliliter of blood ranges from 32 to 76 µg, therefore surpasses 
considerably the amount of bacterial DNA in a specimen from an infected subject. 
[Greenfield & White, 1993], so a high amount of sample DNA should be added to the PCR 
reaction mixture to raise the chances to detect bacterial target sequences.   
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In the case of solid tissues, mechanical homogenization is required to release single cells, 
either for culture or DNA extraction.  A challenge for DNA extraction is when tissues have 
been formalin-fixed and/or paraffin-embedded since there is high risk of DNA damage [Shi 
et al., 2004].   
A summary of the processing of different specimen types for intended mycoplasma 
detection is depicted in Figure 1.  
 
Fig. 1. Differential specimen processing for mycoplasma detection. 
5. Culture vs. nucleic acid amplification methods 
5.1 The gold standard for mycoplasmal infections 
Some genital mycoplasmas, Ureaplasma spp. and M. hominis, are the fastest growing 
species among the Mollicutes, and due to this, culture-based detection is still the first-line 
diagnostic approach. However, extrapolating this particular feature to all pathogenic 
human mycoplasmas is inaccurate. PCR amplification has become essential if fastidious, 
slow-growing, mycoplasma species are sought in certain clinical conditions, especially in 
patients with high risk of invasive infections (neonates) or when invasive methods of 
sampling are required [Waites et al., 2005]. It is well recognized that culture techniques are 
of poor or null value for detection of some mycoplasma species (i.e. M. genitalium) [Razin 
et al., 1998].  
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Since culture rely on viability of mycoplasmas to give a positive result, analytical 
comparisons between culture and PCR invariably will regard the second as less sensitive 
and less specific, which by any means is wrong.  The PCR assay ideally detect target DNA 
sequences present in the sample, whether it comes from live, dead or uncultivable bacteria 
[Persing, 1993].  
Performance of non culture-based detection tests is frequently evaluated against culture, as 
the gold standard. Indirect assays measuring serologic responses as correlates of 
mycoplasma infections, have shown poor sensitivity and required at least 2 serum samples 
taken several days apart, to be informative [Waites, 2000].   
5.2 Culture-enhanced PCR approach  
When very few mycoplasma cells are present in a given specimen there is a high probability 
of obtaining false-negative results, even when the sensitivity of the specific PCR assay is 
high. To overcome this, several authors have developed culture-based pre-enrichment 
protocols for mycoplasmas, mycobacteria and Actinobacillus [Abele-Horn et al., 1998; Díaz-
García et al., 2004; Flemmig et al., 1995; Noussair et al., 2009]. The effects of this procedure 
are, on one hand the dilution of potential undefined inhibitors, and on the other hand the 
promotion of short-term bacterial multiplication. This experimental approach has been termed 
as Culture-enhanced PCR (CE-PCR) [Abele-Horn et al., 1998]. The genomic DNA content in 
overnight enriched mycoplasma cultures are extracted by standard or commercial techniques, 
and then subjected to broad-range or species-specific PCR assays. Under this approach, 
improved detection of M. pneumoniae has been achieved in respiratory specimens [Abele-Horn 
et al., 1998], and of genital mycoplasmas in urine specimens [Díaz-García et al., 2004].  
Another culture-based enrichment approach for improvement of PCR detection of 
mycoplasmas is the cocultivation of these bacteria with permissive immortalized 
mammalian and/or insect cell lines [Kong et al., 2007; Volokhov et al., 2008]. Although this 
approach has been design for intentional screening of cell-derived biological and 
pharmaceutical products, including vaccines and cell culture substrates, it is a potential tool 
for biological enrichment of normally-sterile clinical specimens such as CFS, sera, synovial 
fluid, etc. 
Interestingly, strains of mycoplasma-free Trichomonas vaginalis are readily infected in vitro by 
M. hominis isolates, but not by other urogenital mycoplasmas. The infection can be detected 
by a M. hominis-specific PCR assay after long-term incubation, since the mycoplasma can be 
transmitted between the protozoan cells [Dessi et al., 2006; Rapelli et al., 2001]. The symbiotic 
interplay between M. hominis and T. vaginalis has been well established, as well a significant 
correlation between detection of both microorganisms in vaginal specimens from infected 
women [Dessi et al., 2006].  Thus it is likely to take advantage of such symbiosis and employ 
mycoplasma-free T. vaginalis cultures for specific enrichment of M. hominis-containing 
clinical specimens prior to PCR detection tests.  
6. Commercial molecular diagnostic kits 
Unlike the in-house PCR assays for diagnostic purposes, developed by several researchers, 
the commercial PCR kits are well standardized in terms of sensitivity and specificity, 
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allowing their global use in clinical microbiology laboratories. Thus inter-laboratory 
performance comparisons of such kits are suitable, including testing of several specimen 
types. Indeed, according to the In Vitro Diagnostic Medical Devices Directive 98/79/EC, all 
commercial diagnostic kits used in European countries must have the CE (Conformité 
Européene) label [Dosà et al., 1999].   
Among commercially available real-time PCR kits are intended for M. pneumoniae detection, 
mainly targeting the P1 cytadhesin gene, including Nanogen Mycoplasma pn Q-PCR Alert 
kit (Nanogen Advanced Diagnostics); the Simplexa Mycoplasma pneumoniae kit (Focus 
Diagnostics, California); the Diagenode detection kit for Mycoplasma 
pneumoniae/Chlamydophila pneumoniae (Diagenode SA, Liège, Belgium); the Cepheid 
Mycoplasma pneumoniae ASR kit (Cepheid, Paris, France), and the Venor Mp-Qp PCR 
detection kit (Minerva Biolabs GmbH). It has been shown that these commercial kits had 
acceptable analytical sensitivity and performance with clinical specimens [Touati et al., 
2009].   
Interestingly, many commercially available extraction kits incorporate a buffer to lyses the 
bacteria and a silica matrix membrane (typically in column format) to trap the DNA or 
RNA. Several wash steps are required to remove protein and other macromolecules, and the 
purified DNA and RNA is then eluted from the membrane. Many of the manual extraction 
methods require several centrifugation steps. To reduce hands-on time, operator error, and 
sample contamination, semi-automated DNA or RNA extraction kits and equipment have 
been designed and are commercially available. 
7. PCR, sequencing, phylogeny and molecular epidemiology 
The mycoplasmas may have evolved through regressive evolution from closely related 
Gram positive bacteria with low content of guanine plus cytosine (G+C), probably the 
Clostridia or Erysipelothrix [Bove, 1993; Brown et al., 2007; Razin et al., 1998]. The massive 
gene losses (i.e. genes involved in cell wall and aminoacid biosynthesis) had left 
mycoplasmas with a coding repertoire of 500 to 2000 genes [Sirand-Pugnet et al., 2007]. 
The G+C content in DNA of mycoplasmas varies from 23 to 40 mol%, while genome size 
range is 580–2200 Kbp, much smaller than those of most walled bacteria [Razin et al., 
1998].  
After PCR amplification and sequencing of the conserved 16S rDNA gene sequences from 
representative members of the Mollicutes, the resulting phylogenetic tree was shown to be 
monophyletic, arising from a single branch of the Clostridium ramosum branch 
[International Committee on Systematics of Prokaryotes- Subcommittee on the taxonomy of 
Mollicutes (ICSP-STM), 2010]. The Mollicutes split into two major branches: the AAP 
branch, containing the Acholeplasma, Anaeroplasma and Asteroleplasma genera, and the 
Candidatus Phytoplasma phyla; the other is the SEM branch that includes the Spiroplasma, 
Entomoplasma, Mesoplasma, Ureaplasma and Mycoplasma genera [Johansson et al., 1998; 
Maniloff, 1992; Razin et al., 1998]. Interestingly, the genus Mycoplasma is polyphyletic, with 
species clustering within the Spiroplasma, Pneumoniae and Hominis phylogenetic groups 
[Behbahani et al., 1993; Johansson et al., 1998; Maniloff, 1992]. Nevertheless, additional 
phylogenetic markers such as the elongation factor EF-Tu (tuf) gene, ribosomal protein 
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genes, the 16S-23S rRNA intergenic sequences, etc, have been already used as 
complementary comparative data,  thus there is no unique phylogenetic tree for Mollicutes 
[Razin et al., 1998]. 
There are several in-house species-specific end-point or real-time PCR assays developed to 
detect mycoplasmas in diverse respiratory and urogenital tract infections [Blanchard et al., 
1993b; Loens et al., 2003b; Sung et al., 2006; van Kuppeveld et al., 1992; Wang et al, 1992]. Of 
those clinical entities, more than one mycoplasma species are commonly associated as 
etiologic agents, i.e. urethritis, infertility, pelvic inflammatory disease, etc. [Cassell et al, 
1994b; Taylor-Robinson, 1996]. Thus, simultaneous testing of several species-specific or 
multiplex PCRs to determine all possible pathogenic mycoplasmas associated with a 
particular clinical entity would be very complicated. Combination of PCR amplification of a 
given highly conserved target genome sequence with determination of its nucleotide 
sequences and phylogenetic analysis has been successfully applied for diagnosis and 
identification of mycoplasmal etiologies in male urethritis cases [Hashimoto et al., 2006; 
Yoshida et al., 2002].  
Due to their fastidious growth conditions and frequent cross-reactive antigenic profile, 
identification and typing of human mycoplasmas is a very difficult task. Other approaches 
termed "Random Amplified Polymorphic DNA” (RAPD) or “Arbitrarily Primed PCR" (AP-
PCR), and “Amplified-Fragment Length Polimorphism” (AFLP), are PCR-based typing 
methods used for intra- and inter-species differentiation of mycoplasma isolates. The RAPD 
/ AP-PCR method involves PCR amplification with a single arbitrary primer at low 
stringency, while AFLP method selectively amplifies restriction fragments from whole 
genome. These PCR-based genotyping techniques have allowed faster and reproducible 
typing of mycoplasmas for epidemiologic studies [Cousin-Allery et al., 2000; Geary & 
Forsyth, 1996; Grattard et al., 1995; Iverson-Cabral, et al., 2006; Kokotovic et al., 1999; Rawadi, 
1998; Schwartz et al., 2009].  
8. Conclusion 
In today’s clinical microbiology laboratory, introduction of PCR and other NATs has the 
potential to increase the speed and accuracy of bacterial detection/identification, especially 
of those fastidious microorganisms such as mycoplasmas. However, those molecular assays 
still have serious drawbacks that arise from inadequate acquisition, handling and processing 
of representative clinical specimens. False negative results ultimately can have a significant 
impact on patient management. 
It is widely accepted that molecular methods are more sensitive and specific than culture- 
and serology-based diagnostic approaches but, what does a ‘‘positive’’ test result mean 
clinically?. This issue is a matter of controversy for genital mycoplasmas since the duality of 
their relationship with their host: Is it a commensal or is it a pathogen?. The answer depends 
of an integral clinical evaluation of patients, where a “signs and symptoms”-focused 
sampling will improve laboratory diagnosis. 
In the clinical setting, when negative results after mycoplasma-specific PCR assays are 
reported, the type and quality of the specimen, history of antibiotic treatment of the patient, 
and how representative was the specimen used for the assay, should be taken into account. 
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Therefore, any set of diagnostic results must be reviewed and critically interpreted before 
diagnosis and intervention measures are made.  
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